SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-014637
Filing Date
2022-05-20
Accepted
2022-05-20 16:53:01
Documents
73
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1295946
2 ex31-1.htm EX-31.1 20503
3 ex32-1.htm EX-32.1 7106
  Complete submission text file 0001493152-22-014637.txt   8433728

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nphc-20220331.xsd EX-101.SCH 58133
5 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nphc-20220331_cal.xml EX-101.CAL 64905
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nphc-20220331_def.xml EX-101.DEF 253833
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nphc-20220331_lab.xml EX-101.LAB 468693
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nphc-20220331_pre.xml EX-101.PRE 371823
67 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1200085
Mailing Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071
Business Address 12538 W. ATLANTIC BLVD. CORAL SPRINGS FL 33071 (954) 509-0911
NUTRA PHARMA CORP (Filer) CIK: 0001119643 (see all company filings)

IRS No.: 912021600 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32141 | Film No.: 22948445
SIC: 2833 Medicinal Chemicals & Botanical Products